Daniel K. Wells - Concepedia

Author

Daniel K. Wells

Parker Institute for Cancer Immunotherapy ORCID

Also Known As

D. Wells, Daniel K Wells, Daniel K. Wells, Daniel Wells, Mark Viera, Mehta, Birju, Wells, Daniel, Wells, Daniel K, Wells, Daniel K., Yasin Senbabaoglu

103

Publications

7.2K

Citations

H-Index

Concepts

All Affiliations

Parker Institute for Cancer Immunotherapy Stanford University Memorial Sloan Kettering Cancer Center Cornell University University of California, Los Angeles

About

Daniel K. Wells is an author at Parker Institute for Cancer Immunotherapy specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	3.9K
2	Immunology	10	10	3.8K
3	Cell Biology	5	5	883
4	Engineering	1	1	86
5	Cellular Therapies	1	1	161

Daniel K. Wells

Publications

5.7K

Citations

H-Index

Page 1

	Year	Citations
Clonal replacement of tumor-specific T cells following PD-1 blockade Kathryn E. Yost, Ansuman T. Satpathy, Daniel K. Wells, Nature Medicine Tumor ImmunologyCancer ImmunosurveillanceMedicineImmunologyTumor Immunity	2019	1.5K
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma Rodabe N. Amaria, Sangeetha M. Reddy, Hussein A. Tawbi, Nature Medicine MedicineMelanomaImmunologyTumor ImmunityImmune Checkpoint Inhibitor	2018	797
Genetic Mechanisms of Immune Evasion in Colorectal Cancer Catherine S. Grasso, Marios Giannakis, Daniel K. Wells, Cancer Discovery	2018	534
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction Daniel K. Wells, Marit M. van Buuren, Kristen K. Dang, Cell Tumor ImmunologyCancer ImmunosurveillanceMedicineImmunologyTumor Immunity	2020	507
Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen Santosha A. Vardhana, Madeline A. Hwee, Mirela Berisa, Nature Immunology Autoimmune DiseaseMitochondrial FunctionT CellsPersistent AntigenT-regulatory Cell	2020	489
Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259T Cells in Synovial Sarcoma Sandra P. D’Angelo, Luca Melchiori, Melinda S. Merchant, Cancer Discovery	2018	418
Diabetes-related Mortality in Adults with Cystic Fibrosis. Role of Genotype and Sex Connor Lewis, Scott M. Blackman, Amanda E. Nelson, American Journal of Respiratory and Critical Care Medicine	2014	191
Clonal replacement of tumor-specific T cells following PD-1 blockade Kathryn E. Yost, Ansuman T. Satpathy, Daniel K. Wells,	2019	163
Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results Andras Heczey, Xin Xu, Amy N. Courtney, Nature Medicine Cell TherapyRefractory NeuroblastomaMedicineImmunologyTrial Interim Results	2023	161
TCR signal strength defines distinct mechanisms of T cell dysfunction and cancer evasion Mojdeh Shakiba, Paul Zumbo, Gabriel Espinosa-Carrasco, The Journal of Experimental Medicine ImmunologyImmune Cell TherapyImmunotherapyTst CellsTumor Immunity	2021	140

Page 1